| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Multiple sclerosis | 4 | 0 | |
| Fibromyalgia | 1 | 0 | |
| General health | 1 | 1 | |
| Hyperlipidemia | 1 | 1 | |
| Major depressive disorder | 1 | 0 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 1 |
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Multiple sclerosis | 4 | 0 | |
| Fibromyalgia | 1 | 0 | |
| General health | 1 | 1 | |
| Hyperlipidemia | 1 | 1 | |
| Major depressive disorder | 1 | 0 |
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 1 |